The study included 84 cases of endometrial carcinoma with positive expression of ANXA2 in well, moderately, and poorly differentiated groups (82.4 % [14/17], 95.8 % [23/24], and 100 % [43/43], respectively), which increased with the reduction in the degree of differentiation (Table 2). Here, ANXA2 is linked to endometrial carcinoma.